HUMABFC - Trademark Details
Status: 700 - Registered
Serial Number
79207192
Registration Number
5510331
Word Mark
HUMABFC
Status
700 - Registered
Status Date
2018-07-10
Filing Date
2016-12-14
Registration Number
5510331
Registration Date
2018-07-10
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2018-04-24
Attorney Name
Law Office Assigned Location Code
L90
Employee Name
MARCY, AMY ALFIERI
Statements
Goods and Services
Pharmaceutical products and preparations for the treatment of cancer, autoimmune disorders, inflammatory disorders, viral and bacterial infections, blood diseases; medicines for cancer, autoimmune disorders, inflammatory disorders, viral and bacterial infections, blood diseases; protein supplements; diagnostic kits consisting primarily of monoclonal antibodies and fragment crystallizable proteins, buffers, and reagents for use in disease testing
Goods and Services
Scientific and technological services, namely, scientific research and analysis in the field of monoclonal antibodies and fragment crystallizable proteins; design and development of medical products, namely, pharmaceutical compositions of monoclonal antibodies and fragment crystallizable proteins; scientific study and research in the field of the prevention and the treatment of cancer, autoimmune disorders, inflammatory disorders, viral and bacterial infections, blood diseases; research and development in the field of the prevention and the treatment of cancer, autoimmune disorders, inflammatory disorders, viral and bacterial infections, blood diseases; cellular and molecular biological research; testing, inspection or research of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; consulting in the field of medical research; engineering; genetic engineering; scientific research services using protein expression platform technology for research and development of pharmaceuticals; scientific research services using protein expression platform technology for manufacturing protein-based therapeutics; medical and scientific research of recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; scientific laboratory services in the field of monoclonal antibodies
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2017-05-13
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2017-05-13
Primary Code
042
Current Trademark Owners
Party Type
30 - Original Registrant
Legal Entity Type
33
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Legal Entity Type
33
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Legal Entity Type
33
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Legal Entity Type
33
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Monte L. Falcoff/Jessica S. Sachs
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1343785
International Registration Date
2016-12-14
International Publication Date
2017-05-11
International Renewal Date
2026-12-14
Auto Protection Date
2022-10-01
International Status
001 - Request for extension of protection established
International Status Date
2017-05-11
Priority Claimed In
True
Priority Claimed Date
2016-07-08
First Refusal In
True
Trademark Events
| Event Date | Event Description |
| 2017-05-11 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| 2017-05-13 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2017-05-13 | ASSIGNED TO EXAMINER |
| 2017-05-13 | NON-FINAL ACTION WRITTEN |
| 2017-05-14 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 2017-05-17 | APPLICATION FILING RECEIPT MAILED |
| 2017-05-23 | REFUSAL PROCESSED BY MPU |
| 2017-05-23 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 2017-06-10 | REFUSAL PROCESSED BY IB |
| 2017-10-24 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2017-11-03 | ASSIGNED TO LIE |
| 2017-11-14 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2017-11-14 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2017-12-11 | FINAL REFUSAL WRITTEN |
| 2017-12-11 | FINAL REFUSAL E-MAILED |
| 2017-12-11 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 2018-03-05 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| 2018-03-05 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2018-03-06 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2018-03-17 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2018-04-04 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 2018-04-04 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2018-04-04 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 2018-04-20 | NOTIFICATION PROCESSED BY IB |
| 2018-04-24 | PUBLISHED FOR OPPOSITION |
| 2018-04-24 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2018-07-10 | REGISTERED-PRINCIPAL REGISTER |
| 2018-10-10 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 2018-10-16 | GENERIC MADRID TRANSACTION CREATED |
| 2018-10-16 | GENERIC MADRID TRANSACTION SENT TO IB |
| 2018-12-21 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 2021-03-05 | NEW REPRESENTATIVE AT IB RECEIVED |
| 2021-04-03 | CORRECTION TRANSACTION RECEIVED FROM IB |
| 2021-04-06 | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| 2021-04-09 | NEW REPRESENTATIVE AT IB RECEIVED |
